Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 11Phase 1/2 4Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Other solid neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Multiple Myeloma 1Metastatic Solid Tumors 1Melanoma 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × FANG vaccine × Clear all
NCT00024466 2018-09-19

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
28 enrolled
Plasma cell

Multiple Myeloma

NCT00126685 2013-09-17

Vaccine Therapy in Treating Patients With Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Dermatologic

Melanoma

NCT00016133 2013-05-30

Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

National Cancer Institute (NCI)

Phase 1/2 Completed
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00148993 2011-04-08

Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors

Hadassah Medical Organization

Phase 1/2 Withdrawn
100 enrolled
Other solid neoplasm

Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡